2 articles featuring Terpinolene
Depression is often a systemic physiological state. It disrupts sleep architecture, metabolic recovery, and executive function. Emerging research explores Clinical Endocannabinoid Deficiency (CECD) as a factor in these states. This theory suggests the body may lack the basal tone of endocannabinoids—specifically anandamide (AEA) and 2-arachidonoylglycerol (2-AG)—needed to regulate the stress response and maintain homeostasis.
The tech industry prioritizes high-output cognitive labor, but this relentless demand may lead to High-Functioning Depressive Disorder and anhedonia. Software engineers and data scientists often report that executive function and a stable 'flow state' are the first to degrade. While traditional SSRIs are the standard clinical prescription, they may introduce emotional blunting—a side effect that can compromise the creative problem-solving essential to technical work. For those in high-stakes environments, strategic, low-dose cannabis integration is viewed by some as a potential alternative for mental health management.